Date: 16 December 2020
The Tasmanian Branch of the Pharmacy Guild has announced that internationally renowned Infectious Diseases Specialist and Clinical Professor, Katie Flanagan, will present a key session at the Tasmanian Pharmacy Conference, being held in Hobart 20-21 February 2021.
Professor Flanagan is a clinician-scientist with more than 20 years’ experience in clinical infectious diseases and has an international reputation in vaccine and pathogen immunology.
She has led numerous vaccine immunology trials throughout the world including trials of novel malaria and HIV vaccines in Africa, and trials of the immunological effects of commonly used vaccines in the young and elderly.
Professor Flanagan will examine the rapidly evolving COVID-19 vaccine development landscape - covering the immune response to SARS-CoV-2 and the vaccine approaches taken to develop a COVID-19 vaccine, including some of the more novel approaches.
She will describe the frontrunner constructs in pre-clinical and clinical trials and summarise the emerging results from phase I to III clinical trials.
She will also focus on some of the many challenges and how these are being overcome, including safety issues, scale-up and worldwide distribution.
In addition to her role as Head of Infectious Diseases at the Launceston General Hospital, Professor Flanagan is Chair of the ATAGI COVID-19 Vaccine Utilisation and Prioritisation Committee, Honorary Secretary of the Australian Society for Infectious Diseases (ASID), Chair of the ASID Vaccination Special Interest Group (VACSIG) and a member of the Australian Technical Advisory Group on Immunisation (ATAGI).
To find out more about Professor Flanagan visit the Tasmanian Pharmacy Conference website here.
Contact: The Guild